Showing 101 - 120 results of 2,311 for search '"insulin"', query time: 0.09s Refine Results
  1. 101

    The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications by O. Escribano, N. Beneit, C. Rubio-Longás, A. R. López-Pastor, A. Gómez-Hernández

    Published 2017-01-01
    “…The insulin receptor (IR) presents by alternative splicing two isoforms: IRA and IRB. …”
    Get full text
    Article
  2. 102
  3. 103

    The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer by Jennifer H. Gunter, Amy A. Lubik, Ian McKenzie, Michael Pollak, Colleen C. Nelson

    Published 2012-01-01
    “…An association between the metabolic syndrome and reduced testosterone levels has been identified, and a specific inverse relationship between insulin and testosterone levels suggests that an important metabolic crosstalk exists between these two hormonal axes; however, the mechanisms by which insulin and androgens may be reciprocally regulated are not well described. …”
    Get full text
    Article
  4. 104

    Ectopic Fat and Insulin Resistance: Pathophysiology and Effect of Diet and Lifestyle Interventions by M. Snel, J. T. Jonker, J. Schoones, H. Lamb, A. de Roos, H. Pijl, J. W. A. Smit, A. E. Meinders, I. M. Jazet

    Published 2012-01-01
    “…Ectopic fat is associated with insulin resistance and type 2 diabetes mellitus (T2DM). …”
    Get full text
    Article
  5. 105
  6. 106
  7. 107
  8. 108

    A Survey of Insulin-Dependent Diabetes—Part II: Control Methods by Daisuke Takahashi, Yang Xiao, Fei Hu

    Published 2008-01-01
    “…We survey blood glucose control schemes for insulin-dependent diabetes therapies and systems. …”
    Get full text
    Article
  9. 109

    Roles of the Chemokine System in Development of Obesity, Insulin Resistance, and Cardiovascular Disease by Longbiao Yao, Oana Herlea-Pana, Janet Heuser-Baker, Yitong Chen, Jana Barlic-Dicen

    Published 2014-01-01
    “…This low-grade chronic inflammation is thought to link obesity to insulin resistance and the associated comorbidities of metabolic syndrome such as dyslipidemia and hypertension, which increase risk of type 2 diabetes and cardiovascular disease. …”
    Get full text
    Article
  10. 110

    HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients by Matheus Truccolo Michalczuk, Camila Rippol Kappel, Oscar Birkhan, Ana Carolina Bragança, Mário Reis Álvares-da-Silva

    Published 2012-01-01
    “…There is an association between HCV and insulin resistance (IR), which is currently assessed by HOMA-IR. …”
    Get full text
    Article
  11. 111
  12. 112
  13. 113
  14. 114

    Hubungan Resistensi Insulin dengan Gambaran Klinis Sindrom Ovarium Polikistik by Meliza Wahyuni, Eva Decroli, Putri Sri Lasmini

    Published 2015-09-01
    “…Berdasarkan hasil uji statistik ditemukan hubungan bermakna antara resistensi insulin dengan obesitas (p<0,05) dan tidak ditemukan hubungan bermakna antara resistensi insulin dengan infertilitas, hirsutisme, dan acne (p>0,05).…”
    Get full text
    Article
  15. 115

    Inhibition of MEK1 Signaling Pathway in the Liver Ameliorates Insulin Resistance by Atsunori Ueyama, Nobuhiro Ban, Masanori Fukazawa, Tohru Hirayama, Minako Takeda, Tatsuo Yata, Hiroyasu Muramatsu, Masaki Hoshino, Marii Yamamoto, Masao Matsuo, Yuka Kawashima, Tatsuhiko Iwase, Takehisa Kitazawa, Youichi Kushima, Yuichiro Yamada, Yoshiki Kawabe

    Published 2016-01-01
    “…Although mitogen-activated protein kinase kinase (MEK) is a key signaling molecule and a negative regulator of insulin action, it is still uncertain whether MEK can be a therapeutic target for amelioration of insulin resistance (IR) in type 2 diabetes (T2D) in vivo. …”
    Get full text
    Article
  16. 116

    A Survey of Insulin-Dependent Diabetes—Part I: Therapies and Devices by Daisuke Takahashi, Yang Xiao, Fei Hu, Michael Lewis

    Published 2008-01-01
    “…In type 1 diabetes therapies, the exogenous insulin replacement is generally considered as a primary treatment. …”
    Get full text
    Article
  17. 117
  18. 118

    New Players for Advanced Prostate Cancer and the Rationalisation of Insulin-Sensitising Medication by Jennifer H. Gunter, Phoebe L. Sarkar, Amy A. Lubik, Colleen C. Nelson

    Published 2013-01-01
    “…We discuss current observations of cancer in the context of obesity, diabetes, and insulin-lowering medication. We provide an update on current treatments for advanced prostate cancer and discuss whether metabolic dysfunction, developed during ADT, provides a unique therapeutic window for rapid translation of insulin-sensitising medication as combination therapy with antiandrogen targeting agents for the management of advanced prostate cancer.…”
    Get full text
    Article
  19. 119
  20. 120